Slide background

Our Mission

Galena Biopharma develops and commercializes innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care.

Learn More

Slide background

Currently Enrolling

We are now enrolling women with breast cancer in the Phase 2b NeuVax + Trastuzumab trial to evaluate the NeuVax™ breast cancer vaccine in combination with Herceptin™, which may prevent or delay breast cancer recurrence. Find out if you're eligible.

Learn More

Slide background

Time better spent.

Learn how Galena Biopharma is helping patients with breakthrough cancer pain (BTcP).

Learn More

On Twitter (@galenabiopharma)